Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

recombinant human papillomavirus 11-valent vaccine

A recombinant, 11-valent, human papillomavirus (HPV) vaccine, produced in Hansenula polymorpha, with potential immunoprotective and antineoplastic properties. Upon administration, recombinant HPV 11-valent vaccine may generate humoral and cellular immunity against the 11 undisclosed types of HPV antigens, thereby preventing cervical infection upon exposure to these 11 types of HPV. In addition, this agent may stimulate an antitumoral cellular immune response against cervical cancer associated with HPV infection.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:11-valent recombinant HPV vaccine
11-valent recombinant human papillomavirus vaccine
11-valent recombinant human papillomavirus vaccine (Hansenula polymorpha)
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search